Zacks Research Raises Earnings Estimates for Omnicell

Omnicell, Inc. (NASDAQ:OMCL) – Stock analysts at Zacks Research boosted their FY2025 EPS estimates for shares of Omnicell in a research report issued to clients and investors on Tuesday, July 15th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.31 per share for the year, up from their previous forecast of $0.28. The consensus estimate for Omnicell’s current full-year earnings is $1.09 per share. Zacks Research also issued estimates for Omnicell’s Q4 2025 earnings at $0.17 EPS.

Several other equities analysts also recently weighed in on OMCL. Wells Fargo & Company reissued an “overweight” rating and issued a $37.00 price target (up from $35.00) on shares of Omnicell in a research note on Friday, May 23rd. Bank of America lifted their price objective on shares of Omnicell from $30.00 to $34.00 and gave the company a “neutral” rating in a report on Friday, May 23rd. Piper Sandler reissued an “overweight” rating on shares of Omnicell in a research note on Friday, May 23rd. Wall Street Zen raised Omnicell from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 12th. Finally, Benchmark cut their price target on Omnicell from $62.00 to $40.00 and set a “buy” rating on the stock in a research report on Wednesday, May 7th. Three research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $44.83.

Omnicell Trading Down 3.9%

NASDAQ:OMCL opened at $26.88 on Thursday. Omnicell has a 52 week low of $22.66 and a 52 week high of $55.75. The firm has a 50 day moving average of $29.10 and a 200 day moving average of $34.18. The company has a quick ratio of 1.23, a current ratio of 1.38 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $1.26 billion, a price-to-earnings ratio of 58.44, a PEG ratio of 8.16 and a beta of 0.76.

Omnicell (NASDAQ:OMCL) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.10. Omnicell had a net margin of 1.87% and a return on equity of 4.60%. The company had revenue of $269.67 million during the quarter, compared to analysts’ expectations of $260.18 million. During the same period in the previous year, the company earned $0.03 EPS. The firm’s quarterly revenue was up 9.5% on a year-over-year basis.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Johnson Financial Group Inc. bought a new stake in Omnicell during the fourth quarter worth $37,000. GAMMA Investing LLC raised its position in Omnicell by 37.1% during the second quarter. GAMMA Investing LLC now owns 1,694 shares of the company’s stock worth $50,000 after acquiring an additional 458 shares in the last quarter. Headlands Technologies LLC bought a new stake in Omnicell during the fourth quarter worth $53,000. Huntington National Bank raised its position in Omnicell by 236.4% during the fourth quarter. Huntington National Bank now owns 1,359 shares of the company’s stock worth $61,000 after acquiring an additional 955 shares in the last quarter. Finally, Point72 Hong Kong Ltd acquired a new position in shares of Omnicell in the fourth quarter valued at $101,000. Institutional investors own 97.70% of the company’s stock.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.